← Open Payments lookup

BIMALA DEVKOTA: Open Payments

NPI 1972984599 · LAFAYETTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,200 in 108 payments from 12 companies in 2025. Trend: 2023 $1,761 · 2024 $1,130 · 2025 $1,200

Food & beverage: $1,200
CompanyPaymentsAmount
Lundbeck LLC55$457
E.R. Squibb & Sons, L.L.C.28$261
Otsuka America Pharmaceutical, Inc.11$219
Alkermes, Inc.5$116
Vanda Pharmaceuticals Inc.2$32
Tris Pharma Inc1$23
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$19
Neurocrine BioSciences, Inc.1$18
Orexo US, Inc.1$16
ABBVIE INC.1$14

Products named: REXULTI, ABILIFY ASIMTUFII, ARISTADA, COBENFY, Dyanavel XR, ABILIFY MAINTENA, CAPLYTA, INGREZZA.

Industry payments across IN — which companies pay providers there.